Ondine Biomedical Inc. is a Canadian life sciences company that has emerged as a global leader in photodisinfection-based therapies for preventing and treating a wide range of infections, including those caused by drug-resistant pathogens. Their patented platform technology utilizes non-thermal laser light to activate a photosensitive agent, resulting in the destruction of bacteria, viruses, yeasts, and fungi in just minutes. This innovative approach offers immediate pathogen elimination, prevents resistance formation, and provides safe, fast, and painless treatment options for patients.
One of Ondine's flagship products, Steriwave, is a rapid nasal decolonization therapy that eradicates a broad spectrum of pathogens in the nose within minutes. By eliminating nasal pathogens, Steriwave significantly reduces the risk of infection and transmission, making it a valuable tool in healthcare settings. Ondine also has a robust product pipeline, including treatments for chronic rhinosinusitis, decolonization of burns and wounds, disinfection of endotracheal tubes, and the development of topical antiviral therapy for the upper respiratory tract. With a focus on simple solutions to prevent complex infections, Ondine Biomedical is at the forefront of combating antimicrobial resistance and improving patient outcomes.
Generated from the website